Sonos has delayed the release of its next product — likely the Sub Mini | Big Indy News
Connect with us

Tech

Sonos has delayed the release of its next product — likely the Sub Mini

Published

on

After reporting bumpy third quarter earnings on Wednesday, Sonos announced that it has decided to push back a product launch that was originally penciled in for the near future. The product in question is almost certainly the long-awaited Sub Mini, a more affordable subwoofer that would join the company’s home theater lineup alongside the existing $749 Sub.

The Sub Mini appeared at the FCC in June. If Sonos had followed its typical window of time between that filing and a consumer release, the product would’ve been arriving relatively soon. But Sonos says it’s now been delayed until the fiscal first quarter of 2023. “We always consider the kind of product that it is, and the timing,” CEO Patrick Spence said on the call. “We remain committed to two new product launches each year.”

Sonos spokesperson Erin Pategas confirmed the news to The Verge in an email, saying “I can confirm we decided to push an anticipated product launch from Q4 ’22 into Q1 ’23.” That would put its rescheduled arrival sometime between October and December.

Sonos’ Q3 earnings were well off the mark of the company’s revenue expectations. “We have seen the macroeconomic backdrop become significantly more challenging for us starting in June as the dollar’s appreciation and high inflation have adversely affected consumer sentiment globally, particularly in the categories in which we play,” Spence said in the company’s earnings release.

During a call on Wednesday afternoon, outgoing CFO Brittany Bagley said Sonos is currently holding onto more inventory than it would like and faces a “challenging Q4.” The company pointed to soft demand for the $179 Sonos Ray soundbar as one reason for its revenue miss. But Sonos partially blamed that on a slowdown in TV sales, and the company voiced optimism that the Ray will ultimately prove very successful as its entry-level soundbar on account of positive reviews and its appealing price.

Read the full article here

Tech

Mickey 17, the next film from Parasite director Bong Joon-ho, is out in 2024

Published

on

You’ll have to wait a bit to see Parasite director Bong Joon-ho’s next project. The sci-fi film, called Mickey 17, will hit theaters on March 29th, 2024. The news was revealed via the briefest of teaser trailers, which shows star Robert Pattinson hanging around shirtless in some kind of tube.

The film is based on the novel Mickey 7 by Edward Ashton, which is about a “disposable employee” out on a quest to colonize an icy new world for human habitation (no word yet on where all the extra Mickeys came from). In addition to Pattinson, the film stars Steven Yeun (Nope, Okja), Naomi Ackie (The Rise of Skywalker), Toni Collette (Knives Out), and Mark Ruffalo (everything with the incredible Hulk in it). Outside of the cast, Joon-ho is also working with some notable names behind the camera on this one, including production designer Fiona Crombie (Cruella), costume designer Catherine George (Okja, Snowpiercer), and Dan Glass, a visual effects supervisor known for his work on the Matrix movies.

It’ll likely be a while before we see a proper trailer for Mickey 17, though, as Warner Bros. says the film is currently in production.

Read the full article here

Continue Reading

Tech

In Phoenix, a Taiwanese Chip Giant Builds a Hedge Against China

Published

on

Intel, which hopes to introduce its own new production processes over the next two years, took issue with TSMC’s suggestions that its technology in Arizona will be the most advanced in the United States in 2024. “I would disagree with that point of view,” said Ann Kelleher, the executive vice president who heads Intel’s manufacturing technology development.

State and local officials in Arizona have already agreed to offer financial incentives for the first phase of TSMC’s construction, and the company is expected to apply for federal grants for both phases under the CHIPS Act.

Mr. Chatterji, the White House adviser, estimated that the two new TSMC factories in Arizona, once operating at full capacity, could by themselves fulfill U.S. demands for such advanced chips. But Handel Jones, an analyst who heads International Business Strategies, said TSMC’s factories in Taiwan would still be needed, both because of their production capacity and because they will be making more advanced technology by 2026.

TSMC operates four factories in Taiwan that each can process up to 100,000 semiconductor wafers each month. In Arizona, TSMC initially said the first factory could process 20,000 wafers a month. It now estimates that the two factories’ combined output will be 50,000 a month, or 600,000 a year.

But even relatively small operations in the United States can become important, industry executives said, particularly for individual customers like Apple or for the production of particularly crucial chips in emergencies.

By adding more advanced production technology in the United States, TSMC “would help address vulnerabilities associated with the shortage of semiconductors evident over the past few years,” said Bob LeFort, president of the U.S. arm of Infineon, a big German chip maker.

TSMC’s move is also a sign that the CHIPS Act is having an impact on the plans of big companies, helping to not only spur their spending but galvanize investments by companies that supply them with production tools and materials.

Read the full article here

Continue Reading

Tech

Elon Musk’s Neuralink is reportedly facing a federal probe on animal welfare grounds

Published

on

Neuralink, the brain implant company founded by Elon Musk, is reportedly facing a federal probe over the treatment of animals used in its experiments. Reuters reports that a probe was recently opened by the US Department of Agriculture’s (USDA) inspector general and focuses on potential violations of the Animal Welfare Act. A spokesperson for the USDA inspector general declined to comment to Reuters on its report.

Although Reuters says it’s unclear how wide-ranging the probe is, the news agency details a range of concerns over animal welfare raised in interviews with more than 20 current and former Neuralink employees. These include reports that, in one experiment, 25 out of 60 pigs allegedly had the wrong size of device installed as part of a study, while on another occasion, two separate pigs had devices installed on the wrong vertebra, leading to one needing to be euthanized to end its suffering. 

Staffers are reportedly pushed to meet ambitious deadlines

Neuralink’s aim is to develop ways for the human brain to interface directly with computers to help treat a range of neurological conditions and even help paralyzed people walk. So far, the company has made a number of public demonstrations of its technology being used by animals, including showing a monkey playing Pong with its brain and another typing on a computer using an implant.

It is common for animals used in scientific tests to be killed after experiments are completed so that their autopsies can provide further data. But current and former Neuralink employees interviewed by Reuters said that testing mistakes can lead to excess deaths by requiring tests to be repeated. They can also make the resulting data less accurate. Reuters reports that Neuralink has killed around 1,500 animals since 2018.

None of this is firm evidence of wrongdoing (and Reuters notes that Neuralink has passed all USDA inspections), but employees have reportedly raised concerns internally that Musk’s drive for quick progress has created an environment filled with what Reuters calls “under-prepared and over-stressed staffers scrambling to meet deadlines.” Musk’s attempts to motivate employees to work faster reportedly include telling staff to imagine they have a bomb strapped to their heads. Reuters says the CEO also wrote in an email in February this year, “In general, we are simply not moving fast enough. It is driving me nuts!”

Publicly, Musk has been bullish about the potential for Neuralink to start human trials in the near future. At a recent event, the Tesla and now Twitter CEO said that he hoped to install the device in a human’s head within the next six months. Musk previously said he hoped to start human trials in 2020 and then in 2022.

Neuralink has faced criticism for its treatment of animals before. Earlier this year, a nonprofit called the Physicians Committee for Responsible Medicine (PCRM), which is against the use of animals in medical experiments, alleged that, in a study funded by Neuralink, scientists at the University of California, Davis treated monkeys involved in one of its experiments inhumanely. Neuralink responded to the allegations, saying that “the facilities and care at UC Davis did and continue to meet federally mandated standards.” 

Neuralink did not respond to The Verge’s request for comment. Reuters’ report is well worth reading in its entirety. 

Read the full article here

Continue Reading

Trending